Not Signed In - [ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
Speech Disorders |
|
|
Clinical Trial: Therapeutic Processes and Treatment Outcome in Adolescents with Anxiety Disorders
This study is no longer recruiting patients.
|
Purpose
The purpose of this study is to examine the relationship between different aspects of cognitive behavior therapy (CBT) and treatment outcome.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Anxiety Disorders | Behavior: Cognitive Behavioral Therapy | Phase IV |
MedlinePlus related topics: Anxiety
Study Type: Interventional
Study Design: Treatment, Non-Randomized, Open Label, Active Control, Single Group Assignment, Efficacy Study
Official Title: Process as a Predictor of Outcomes in CBT for Youth
Expected Total Enrollment: 130
Study start: September 2002; Study completion: August 2005
Anxiety disorders are common among children; if untreated, they can negatively affect children's lives. Evidence suggests that CBT can benefit children with anxiety disorders, but the causal mechanisms between therapy and beneficial outcomes have not been thoroughly investigated.
Audio and videotaped sessions of children currently receiving CBT and those who received CBT in previous trials will be examined. Various rating scales will be used to rate therapeutic alliance, child involvement, and therapist flexibility for each session of CBT. To evaluate potential process variables that contribute to participant drop-out, this study will compare the early process variables for children who complete treatment and for those who discontinue treatment.
Eligibility
Ages Eligible for Study: 8 Years - 13 Years, Genders Eligible for Study: Both
Criteria
Inclusion criteria:
- Diagnosis of separation anxiety disorder, generalized anxiety disorder, or social phobia
- At least one English-speaking parent
Exclusion criteria:
- IQ < 80
- Psychotic symptoms
Location Information
Pennsylvania
Temple University, Philadelphia, Pennsylvania, 19122, United States
Australia, New South Wales
Macquarie University, Sydney, New South Wales, 2109, Australia
More Information
Child and Adolescent Anxiety Disorders Clinic homepage
Record last reviewed: January 2005
Last Updated: January 31, 2005
Record first received: October 29, 2003
ClinicalTrials.gov Identifier: NCT00071630
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
Resources
- (National Women's Health Information Center, OWH, HHS)
- Apraxia of Speech (National Institute on Deafness and Other Communication Disorders)
email this page
print this page
bookmark this page
feedback on this page
